Skip to main content
CO

Cellular Origins

Cellular Origins provides the Constellation ecosystem, an advanced mobile robotic platform designed for cell therapy manufacturing automation. This system integrates existing processes and technologies to deliver GMP-compliant, full automation for scaling production. The platform increases efficiency, optimizes facility space, and reduces the cost of goods for cell and gene therapy developers.

Melbourne, United KingdomFounded 2022683K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

The cell and gene therapy (CGT) industry faces significant challenges in scaling production due to reliance on manual processes, labor shortages, high costs, and inefficient use of space. Current manufacturing approaches struggle to meet the increasing demand for CGTs, hindering wider patient access to these life-saving treatments.

Solution

Cellular Origins offers Constellation, a robotic automation platform designed to industrialize and digitize cell therapy manufacturing at scale. Constellation integrates existing, proven cell therapy technologies into a single, automated ecosystem, streamlining processes and reducing the need for extensive process redevelopment. The platform's modular design and free-roaming robots enable flexible adaptation to specific therapy requirements, ensuring consistency, quality, and speed. By automating workflows, Constellation reduces labor requirements, maximizes facility efficiency, and de-risks production, providing a seamless pathway from lab to industrial scale. The system facilitates GMP-compliant manufacturing, enabling cell therapy developers to scale their operations without compromising on established processes.

Target Audience

Cellular Origins primarily targets cell and gene therapy developers and manufacturers seeking to scale their production processes, reduce costs, and improve efficiency while maintaining regulatory compliance.

Features

  • Robotic integration of cell therapy manufacturing equipment selected by the cell therapy company
  • Modular design with free-roaming robots for flexible adaptation and quick replacements
  • Automated workflows to reduce manual handling and minimize errors
  • Closed system operation for maintaining sterility and reducing contamination risks
  • Integrated safety system allowing human operators to work in the same space as robots
  • Compact footprint, achieving over 30x space optimization compared to traditional manufacturing setups
  • Data-rich production processes for enhanced monitoring, control, and traceability
This profile is AI-generated and may contain inaccuracies.